Home
Market Capitalization of Mangalam Drugs And Organics Ltd

Mangalam Drugs and Organics Ltd
NSE: MANGALAM
Market Cap
Key Highlights
- The Market Cap of Mangalam Drugs and Organics Ltd is ₹ 163.98 crore as of 21 Feb 25 .
- The Latest Trading Price of Mangalam Drugs and Organics Ltd is ₹ 103.6 as of 21 Feb 15:30 .
- The Dividend Payouts of Mangalam Drugs and Organics Ltd is ₹ 0.5 as of Dec 21, 2017 .

Mangalam Drugs and Organics Ltd
NSE: MANGALAM
Share Price
Market Price of Mangalam Drugs and Organics Ltd
1M
1Y
3Y
5Y
Last Ten Days Market Price
Date | |
---|---|
21 Feb 2025 | 103.6 |
20 Feb 2025 | 103.95 |
19 Feb 2025 | 102.2 |
18 Feb 2025 | 106.75 |
17 Feb 2025 | 107.2 |
14 Feb 2025 | 110.2 |
13 Feb 2025 | 110.5 |
12 Feb 2025 | 110.75 |
11 Feb 2025 | 115.25 |
10 Feb 2025 | 113.95 |
SWOT Analysis Of Mangalam Drugs and Organics Ltd
BlinkX Score for Mangalam Drugs and Organics Ltd
Asset Value vs Market Value of Mangalam Drugs and Organics Ltd
Market Value
₹ 0
Asset Value
₹ 0
* All values are in ₹ crores
Competitive Comparison of Market Cap
Key Valuation Metric of Mangalam Drugs and Organics Ltd
Historical P/E Ratio of Mangalam Drugs and Organics Ltd
The price-to-earnings ratio (P/E ratio) is a valuation measure calculated by dividing a company's current share price by its earnings per share. P/E Ratio Formula P/E ratio = (CMP of share/ Earning per share) Types of Price to Earning Ratio 1. Forward P/E ratio: It is calculated by simply dividing the price of a single unit of a company along with the estimated earnings of a company derived from its future earning guidance. 2. Trailing P/E ratio: It is the most common metric used by investors where past earnings of a company over a period are considered.
Historical P/E Ratio of Mangalam Drugs and Organics Ltd
Historical Revenue of Mangalam Drugs and Organics Ltd
Revenue term means the amount of money a company earns from its primary business activities such as the sales of its products & services.\r\r\n\r\r\nTypes of Revenue:\r\r\n\r\r\n1. Operating revenue: It refers to the income generated from the core business activities, which are sales of goods or services rendered.\r\r\n\r\r\n2. Non-Operating revenue: It is the income generated from secondary sources unrelated to the primary business. Examples include rents, dividends, interest, and royalty fees.\r\r\n\r\r\nFormula for Revenue:\r\r\n\r\r\nThe formula for calculating revenue is based on two goods & services:\r\r\n\r\r\nFor goods:\r\r\nRevenue = Avg unit price x Number of Units sold\r\r\n\r\r\nFor services:\r\r\nRevenue = Avg unit price x Number of Customers served.
Historical Revenue of Mangalam Drugs and Organics Ltd
Historical EBITDA of Mangalam Drugs and Organics Ltd
PBIDT stands for Profit Before Interest, Depreciation, and Taxes. It is a financial metric that measures a company's profitability before accounting for interest expenses, depreciation of assets, and taxes. Formula to calculate PBIDT: PBIDT = Net Income + Interest + Depreciation + Taxes or PBIDT = Operating Income + Depreciation + Taxes PBIDT vs EBITDA vs EBIT vs EBT: Here is a brief explanation of the differences: - PBIDT (Profit Before Interest, Depreciation, and Taxes) includes taxes in its calculation, unlike EBITDA. - EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) excludes taxes and interest, focusing on operational performance. - EBIT (Earnings Before Interest and Taxes) excludes interest and taxes, providing a measure of core operational profitability. - EBT (Earnings Before Taxes) includes all operating income but does not account for interest expenses. Conclusion: PBIDT, similar to EBITDA, is a measure of operational profitability but includes taxes in its calculation.
Historical EBITDA of Mangalam Drugs and Organics Ltd
Historical Net Profit of Mangalam Drugs and Organics Ltd
Net profit is the amount of money a company retains after accounting for all expenses, depreciation, interest, taxes, and other deductions.\r\r\n\r\r\nNet Profit formula is expressed as:\r\r\n\r\r\nNet Profit = Total Revenue - Total Expense\r\r\n\r\r\nNet Profit Margin Ratio:\r\r\n\r\r\nNet Profit Margin Ratio = Net Profit / Total Revenue
Historical Net Profit of Mangalam Drugs and Organics Ltd

Mangalam Drugs and Organics Ltd
NSE: MANGALAM
DIVIDENDPAYOUT
About Mangalam Drugs and Organics Ltd
- Mangalam Drugs and Organics Ltd was formerly incorporated on April 18, 1972 as a private limited company with the name Advent Pharma Pvt Ltd. On July 1, 1997, the Company changed their name from Advent Pharma Pvt Ltd to Mangalam Drugs and Organics Pvt Ltd. Thereafter, the Company converted into a Public Limited Company and name of the Company was changed from Advent Pharma Ltd to Mangalam Drugs and Organics Ltd on August 10, 2001.
- The company was promoted by Dhoot family.
- The company was established with a view to set up a plant for manufacture of organic and inorganic chemicals. The company is engaged in the manufacturing of chemicals, such as active pharma ingredients (API) perfumery, disperse dye intermediates, bulk drugs and bulk drugs intermediates.
- The company has their manufacturing facilities at Vapi in Gujarat and Sangamner in Maharashtra.
Mangalam Drugs and Organics Ltd News Hub
Mangalam Drugs and Organics reports standalone net profit of Rs 2.68 crore in the June 2024 quarter
Net profit of Mangalam Drugs and Organics reported to Rs 2.68 crore in the quarter ended June 2024 a
Read more
14 Aug 24
Mangalam Drugs and Organics to declare Quarterly Result
Mangalam Drugs and Organics will hold a meeting of the Board of Directors of the Company on 13 Augus
Read more
10 Aug 24
Mangalam Drugs and Organics AGM scheduled
Mangalam Drugs and Organics announced that the 51th Annual General Meeting (AGM) of the company will
Read more
25 Sept 24
Mangalam Drugs and Organics to table results
Mangalam Drugs and Organics will hold a meeting of the Board of Directors of the Company on 14 Novem
Read more
08 Nov 24